BFM
RXDX

Boothbay Fund Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Boothbay Fund Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,121
Closed -$2.59M – 2271
2023
Q1 		$2.59M Sell
24,121
-30,976
-56% -$3.32M 0.05% 447
2022
Q4 		$6.06M Buy
55,097
+16,347
+42% +$1.8M 0.14% 125
2022
Q3 		$2.29M Buy
+38,750
New +$2.29M 0.06% 435